The HealthTech Activator’s (HTA) clinical validation workshop, Clinical Investigation Process for Medical Devices, will take place in Auckland, across two half days: Tuesday 19 November 12:00pm - 5:00pm and Wednesday 20 November 9:00am - 1:00pm, attendance to both days is required.

This workshop aims to provide you with an overview of the clinical investigation process and an understanding of medical device company responsibilities as sponsor, enabling informed business planning and effective engagement with service providers.

This workshop will cover the following:

Introduction to the clinical investigation process and planning
Overview of key standards, regulations, and compliance requirements
Sponsor responsibilities and key aspects of clinical investigation design
Clinical investigation start-up activities and requirements, including the NZ ethics and regulatory landscape
Conducting and closing a clinical trial, including data quality, risk, and operational oversight

Who is this workshop for?

This workshop is for medical device companies that need clinical data to support market access.

Learn and engage with experts.

The workshop is run by Julie Jones from BioValeo. Julie has over 20 years of experience in clinical research covering various therapeutic areas, investigational products, devices, and all trial phases.

Event details

Workshop: Tuesday 19 November 2024, 12:00pm - 5:00pm (A light lunch & afternoon tea included) and Wednesday 20 November 2024, 9:00am - 1:00pm (Morning tea included)
The workshop content will be delivered across two half days, attendance to both days is required
Hosted in-person at Callaghan Innovation, Auckland
Cost: $195 (incl. GST and booking fee)
Attendance is limited to two attendees per company

To confirm your place please register no later than 12 November 2024. Spaces are limited, and a waitlist will open once the workshop is fully subscribed.

About the presenter:

LinkedIn: Julie Jones
CEO, BioValeo

Julie has over 20 years of experience in clinical research, conducting studies in New Zealand and internationally. With in-depth knowledge of New Zealand's clinical research regulations and quality standards, Julie's extensive experience covers various therapeutic areas, investigational products, devices, and all trial phases.

__

Contact the HealthTech Activator (HTA) team for more information or explore the HTA website here.